Hazel J. Dyke

1.3k total citations
30 papers, 911 citations indexed

About

Hazel J. Dyke is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Hazel J. Dyke has authored 30 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in Hazel J. Dyke's work include Phosphodiesterase function and regulation (11 papers), Receptor Mechanisms and Signaling (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Hazel J. Dyke is often cited by papers focused on Phosphodiesterase function and regulation (11 papers), Receptor Mechanisms and Signaling (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Hazel J. Dyke collaborates with scholars based in United Kingdom, United States and Australia. Hazel J. Dyke's co-authors include John G. Montana, Nicholas C. Ray, Peter Lockey, David E. Clark, Melanie Wong, Alan G. Roach, Dennis Norman, Eric J. Thomas, Stephen P. Wren and Harold W. Moore and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Hazel J. Dyke

30 papers receiving 844 citations

Peers

Hazel J. Dyke
Christian Mang Germany
Peter Lockey United Kingdom
Ralph Mosley United States
Armand B. Cognetta United States
George J. Cullinan United States
Hélène Perrier Canada
Giuseppina Morini Italy
Craig H. Miller United States
Jinsai Shang United States
Aliaa Abdelrahman Germany
Christian Mang Germany
Hazel J. Dyke
Citations per year, relative to Hazel J. Dyke Hazel J. Dyke (= 1×) peers Christian Mang

Countries citing papers authored by Hazel J. Dyke

Since Specialization
Citations

This map shows the geographic impact of Hazel J. Dyke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel J. Dyke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel J. Dyke more than expected).

Fields of papers citing papers by Hazel J. Dyke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazel J. Dyke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel J. Dyke. The network helps show where Hazel J. Dyke may publish in the future.

Co-authorship network of co-authors of Hazel J. Dyke

This figure shows the co-authorship network connecting the top 25 collaborators of Hazel J. Dyke. A scholar is included among the top collaborators of Hazel J. Dyke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazel J. Dyke. Hazel J. Dyke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Webster, Scott P., Margaret Binnie, Karen Sooy, et al.. (2010). Modulation of 11β-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles. Bioorganic & Medicinal Chemistry Letters. 20(11). 3265–3271. 22 indexed citations
2.
Clark, Robin D., Nicholas C. Ray, Karen Williams, et al.. (2008). 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity. Bioorganic & Medicinal Chemistry Letters. 18(4). 1312–1317. 40 indexed citations
3.
Dyke, Hazel J.. (2007). Novel 5,6-dihydropyrazolo-[3,4-E][1,4]diazepin-4 (1H)-one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. Expert Opinion on Therapeutic Patents. 17(9). 1183–1189. 6 indexed citations
4.
Ray, Nicholas C., Robin D. Clark, David E. Clark, et al.. (2007). Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators. Bioorganic & Medicinal Chemistry Letters. 17(17). 4901–4905. 24 indexed citations
5.
Clark, Robin D., Nicholas C. Ray, Paul Blaney, et al.. (2007). 2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(20). 5704–5708. 7 indexed citations
6.
Dyke, Hazel J., Peter Lockey, Dennis Norman, et al.. (2006). Quinazoline and benzimidazole MCH-1R antagonists. Bioorganic & Medicinal Chemistry Letters. 17(5). 1403–1407. 17 indexed citations
7.
Birch, Helen L., George M. Buckley, Hazel J. Dyke, et al.. (2005). Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(23). 5335–5339. 50 indexed citations
8.
Buckley, George M., Hazel J. Dyke, Alan F. Haughan, et al.. (2004). Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 15(3). 751–754. 46 indexed citations
9.
Clark, David E., Hazel J. Dyke, Peter Lockey, et al.. (2004). Structure–activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(15). 4099–4102. 36 indexed citations
10.
Billah, Motasim, George M. Buckley, Nicola J. Cooper, et al.. (2002). 8-Methoxyquinolines as PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(12). 1617–1619. 18 indexed citations
11.
Montana, John G. & Hazel J. Dyke. (2002). Update on the therapeutic potential of PDE4 inhibitors. Expert Opinion on Investigational Drugs. 11(1). 1–13. 155 indexed citations
12.
Buckley, George M., Nicola Cooper, Hazel J. Dyke, et al.. (2002). 8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters. 12(12). 1613–1615. 12 indexed citations
13.
Buckley, George M., Nicola J. Cooper, Richard Davenport, et al.. (2002). 7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 Inhibitors: A Potential Treatment for Asthma. Bioorganic & Medicinal Chemistry Letters. 12(3). 509–512. 17 indexed citations
14.
Billah, M. Motasim, Nicola J. Cooper, Michael Minnicozzi, et al.. (2002). Pharmacology of N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline Carboxamide (SCH 351591), a Novel, Orally Active Phosphodiesterase 4 Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 302(1). 127–137. 27 indexed citations
15.
Barnes, Michael R., Nicola Cooper, Richard Davenport, et al.. (2001). Synthesis and structure–activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(8). 1081–1083. 39 indexed citations
16.
Dimitriou, Gabriel, Anne Greenough, Hazel J. Dyke, & Gerrard F. Rafferty. (2000). Maximal airway pressures during crying in healthy preterm and term neonates. Early Human Development. 57(2). 149–156. 29 indexed citations
17.
Buckley, George M., Nicola Cooper, Hazel J. Dyke, et al.. (2000). 7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters. 10(18). 2137–2140. 15 indexed citations
18.
Dyke, Hazel J. & John G. Montana. (1999). The therapeutic potential of PDE4 inhibitors. Expert Opinion on Investigational Drugs. 8(9). 1301–1325. 33 indexed citations
19.
Cooper, Nicola, Hazel J. Dyke, Lewis Gowers, et al.. (1998). PDE4 inhibitors: New xanthine analogues. Bioorganic & Medicinal Chemistry Letters. 8(20). 2925–2930. 7 indexed citations
20.
Montana, John G., George M. Buckley, Nicola Cooper, et al.. (1998). Aryl sulfonamides as selective PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(19). 2635–2640. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Mang Breakdown of academic impact, for papers by Peter Lockey Breakdown of academic impact, for papers by Ralph Mosley Breakdown of academic impact, for papers by Armand B. Cognetta Breakdown of academic impact, for papers by George J. Cullinan Breakdown of academic impact, for papers by Hélène Perrier Breakdown of academic impact, for papers by Giuseppina Morini Breakdown of academic impact, for papers by Craig H. Miller Breakdown of academic impact, for papers by Jinsai Shang Breakdown of academic impact, for papers by Aliaa Abdelrahman
Rankless by CCL
2026